EP3002002B1 - Nouveau procédé d'administration - Google Patents

Nouveau procédé d'administration Download PDF

Info

Publication number
EP3002002B1
EP3002002B1 EP15195229.8A EP15195229A EP3002002B1 EP 3002002 B1 EP3002002 B1 EP 3002002B1 EP 15195229 A EP15195229 A EP 15195229A EP 3002002 B1 EP3002002 B1 EP 3002002B1
Authority
EP
European Patent Office
Prior art keywords
medicine
storage chamber
cassette
dosing
impacter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP15195229.8A
Other languages
German (de)
English (en)
Other versions
EP3002002A1 (fr
Inventor
Sten-Magnus Aquilonius
Christer Nyström
Sören NYGREN
Carl-Olof SJÖBERG
Jan Kranse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sensidose AB
Original Assignee
Sensidose AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sensidose AB filed Critical Sensidose AB
Publication of EP3002002A1 publication Critical patent/EP3002002A1/fr
Application granted granted Critical
Publication of EP3002002B1 publication Critical patent/EP3002002B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills
    • B65D83/0409—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills the dispensing means being adapted for delivering one article, or a single dose, upon each actuation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
    • A61J7/0481—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers working on a schedule basis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00—General characteristics or adaptations
    • A61J2200/30—Compliance analysis for taking medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
    • A61J7/0418—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with electronic history memory
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
    • A61J7/0427—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system
    • A61J7/0445—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system for preventing drug dispensing during a predetermined time period
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2583/00—Containers or packages with special means for dispensing contents
    • B65D2583/04—For dispensing annular, disc-shaped or spherical or like small articles or tablets
    • B65D2583/0472—For dispensing annular, disc-shaped or spherical or like small articles or tablets characterised by the dispensing action
    • B65D2583/0477—For dispensing annular, disc-shaped or spherical or like small articles or tablets characterised by the dispensing action the container is maintained in the same position during the dispensing of several successive articles or doses
    • B65D2583/049—One rotational action of a cylindrical, disc-like or sphere-like element around its own axis, e.g. step-by-step, reciprocating

Definitions

  • the invention relates to a new administration method, in particular one that uses a certain hand held medicine dosing and dispensing device.
  • the drug therapies used to treat or otherwise control a number of chronic diseases such as, but not limited to, Parkinson's disease, epilepsy, cancer, depression, schizophrenia, diabetes, arthritis and asthma and diseases requiring anti-coagulants, anti-arrhythmics and/or analgesia often have a narrow therapeutic window and produce significant side effects when dosing is non-optimal.
  • the timing of doses is therefore critical to maintain drug levels within desired levels and it is important that administered doses are as accurate as possible to reduce the effects that can otherwise arise from over or under dosing.
  • EP 1 058 660 B1 describes a procedure for dosing a medicine for dispensing to a single patient from a supply of equally large units or partial doses of the medicine in the form of single tablets or pellets where each unit or partial dose contains from approximately 20 to approximately 2 weight percent of the therapeutic total dose to be administered to the patient on a single occasion.
  • This procedure allows the dispensing of highly variable doses of a medicine from a single supply of the medicine.
  • the miniaturization associated with producing a portable dosing and dispensing device has been found to encourage the formation of bridges of tablets within the dosing and dispensing device, which impacts on the efficiency of any such device.
  • FIG. 1 shows a bridge 1 of tablets 2 formed within a funneled channel 3 leading to an outlet 4 of a storage chamber 5.
  • EP 0 287 335 discloses a device that seeks to overcome the problems associated with the formation of bridges of tablets in a funneled channel of a tablet dispensing device.
  • the device disclosed in EP 0 287 335 includes a feed channel having a flexible wall to agitate tablets in the feed channel.
  • the flexible wall in order to agitate tablets in the feed channel, the flexible wall must flex both outwardly and inwardly in order to provide the required vibration and therefore necessitates the provision of space in an outward direction into which the wall may flex. The requirement for this outward space results in a larger device than would otherwise be required in order to store the required number of units of medicine.
  • a new administration method in which a certain hand held dosing and dispensing device is employed to deliver the medicine in that method (or regime).
  • a hand held dosing and dispensing device is as described herein.
  • a medicament for use in the treatment of a disease wherein the medicament is orally administered on one to ten occasions daily using a hand held medicine dosing and dispensing device, and wherein:
  • the invention relates to a medicament for use in an administration method, which is therefore referred to herein as "the method of the invention".
  • the administration will be to a patient, preferably a human patient (e.g. one that is able to manage the hand-held device of the invention).
  • the administration method of the invention may specify a certain frequency of administration of the relevant medicament, for instance it may relate to a certain dosing regime (i.e. administration on one to ten occasions daily is specified), and it may therefore be referred to herein as "the (dosing) regime of the invention”.
  • the hand held dosing and dispensing device used to administer the relevant medicament is referred to herein as "the device of the invention”.
  • the term "medicament” when used herein refers to an active compound, which is known to treat (including therapeutic and/or prophylactic treatment) a certain disease or condition. It may refer to the active component as such, e.g. an organic compound or a pharmaceutically acceptable salt, solvate or prodrug thereof. It may also refer to that active compound (or salt, solvate or prodrug thereof) as a component of a pharmaceutically acceptable composition/formulation, i.e. one that may further contain a pharmaceutically acceptable adjuvant, diluent or carrier (and/or other suitable ingredients of a composition/formulation).
  • Such salts may be formed by conventional means, for example by reaction of a free acid or a free base form of the relevant active compound with one or more equivalents of an appropriate acid or base, optionally in a solvent, or in a medium in which the salt is insoluble, followed by removal of said solvent, or said medium, using standard techniques (e.g. in vacuo, by freeze-drying or by filtration).
  • Salts may also be prepared by exchanging a counter-ion of a compound of the invention in the form of a salt with another counter-ion, for example using a suitable ion exchange resin.
  • active compounds that may be used as the medicament (or as a component of the medicament) in the method/regime of the invention may possess pharmacological activity as such
  • certain pharmaceutically-acceptable (e.g. "protected") derivatives of the relevant active compound may exist or be prepared which may not possess such activity, but may be administered and thereafter be metabolised in the body to form the relevant active compound.
  • Such compounds (which may possess some pharmacological activity, provided that such activity is appreciably lower than that of the active compounds to which they are metabolised) may therefore be described as "prodrugs" of compounds of the invention.
  • prodrug includes compounds that form the relevant active compound in an experimentally-detectable amount, within a predetermined time (e.g. about 1 hour), following administration. All prodrugs of the relevant active compounds may be the active compound in the medicament (or a component of the medicament).
  • the medicament that may be administered may be the active compound (i.e. including salts, solvates or prodrugs thereof) as such or it may be a pharmaceutically acceptable composition/formulation comprising that active compound, for instance in admixture with one or more adjuvant, diluent or carrier.
  • the active compound may also be a component of a pharmaceutically acceptable composition, which has a sustained and/or controlled release characteristic (and therefore doses may need to be taken relatively less frequently), for instance it may comprise another component which, in combination with the active component, provides for the sustained and/or controlled release characteristic.
  • the further component may be a distinct component (e.g. a certain excipient or a swelling agent, such as hydroxypropyl methylcellulose or the like; such a component may comprise from about 5% to about 50% parts by weight, per 100 parts by weight of the formulation) or the active compound may be embedded in a matrix of insoluble substance, the active ingredient being released as a result of its solubility.
  • Other standard sustained and/or controlled release formulations are included within the scope of the invention.
  • the sustained and/or controlled may be an inherent property of the active ingredient.
  • sustained release we include formulations/compositions, which when administered (e.g. orally administered), the active ingredient will be released for absorption into the blood stream over a period of time (that is longer than the period that the active ingredient would normally be released into the blood if it did not have the sustained (or controlled) release properties or characteristics).
  • a medicament may be administered as hereinbefore defined, for instance once daily or more, i.e. up to ten times daily. However, conveniently, the medicament may be administered even more frequently using the device of the invention, if the disease to be treated requires.
  • the route of administration is oral and the active compound is taken as a unit consisting of a tablet or capsule (or multiple units, i.e. several tablets or capsules).
  • the active compound may be a component of a pharmaceutically acceptable formulation as hereinbefore defined (which includes a sustained and/or controlled release formulation).
  • the hand held medicine dosing and dispensing device of the invention i.e. "the device of the invention" is used to administer the medicament (i.e. the active compound, or formulation containing it) orally on a distinct number of occasions per day.
  • the medicament i.e. the active compound, or formulation containing it
  • the medicament may be taken by the administration of several partial doses or units (e.g. microtablets) that together make up the total dose to be administered on each single occasion.
  • the device of the invention allows for the dose on each occasion to be fine-tuned, depending on the requirements of the disease/patient.
  • the medicament i.e. the active compound or formulation containing it
  • it may be once daily (by which we mean that the entire recommended daily dose is taken on one occasion, or in one batch, in a 24 hour period) or more than once daily, for instance two, three or four times daily (i.e. the recommended daily dose is administered on two, three or four occasions, or in two, three or four batches, in a 24 hour period).
  • each batch is spread over the 24 hours in a manner appropriate to the disease or condition to be treated.
  • the device of the invention lends itself to be able to allow the patient or user to be able to administer the medicament in any predetermined dosing regime, i.e. in any quantity on any given number of occasions.
  • the medicament i.e. the active compound or formulation containing it
  • the number of doses is preferably 3 or more (e.g. 4 or more, such as 5 to 10 doses) daily.
  • the device of the invention advantageously lends itself to such administration methods (or dosing regimes), given that it allows for the dispensing of highly variable doses of a medicine, including such spreading of a daily dose over the 24 hour period.
  • the medicament i.e. active compound, or formulation containing it
  • the number of doses will be less frequent, for instance 4 or less daily (e.g. 3 or less, such as 2 and most preferably once daily, if the formulation allows).
  • the dose is taken before sleep (e.g. before night-time, before the patient sleeps) or after sleep (e.g. in the morning, after the patient awakes).
  • the device of the invention may also be employed to deliver such daily doses (in particular once, twice or three times daily).
  • the number of occasions that the medicament will need to be taken in a 24 hour period will depend on the disease and the patient to be treated. For instance, if the medicament is a sustained release formulation (or the disease to be treated is one in which the daily frequency is low regardless of the type of formulation), then the frequency of administration in a 24 hour period will be relatively less (e.g. three or less occasions daily), but if the disease to be treated is one where a higher daily frequency is necessary e.g. Parkinson's, then the number of occasions may be relatively more, e.g. three or more (e.g. three to ten, such as five to ten, occasions daily).
  • a daily dose refers to the amount of active compound required by the patient in a 24 hour period, to treat a certain disease or condition.
  • the actual daily dose i.e. quantity of medicament or active compound
  • oral dosages may range from between about 0.01 mg/kg of body weight per day (mg/kg/day) to about 100 mg/kg/day, preferably about 0.01 to about 10 mg/kg/day, and more preferably about 0.1 to about 5.0 mg/kg/day.
  • a typical total daily dose may therefore correspond to 100 to 2500 mg (however, more specific daily doses are mentioned hereinafter).
  • each unit or partial dose typically contains between about 0.01 mg to about 500 mg, and preferably between about 1 mg to about 100 mg, of the active ingredient.
  • a partial dose (or unit/microtablet) may be between about 1 mg and 25 mg (e.g.
  • compounds may be administered in a once daily dose, or the total daily dose may be administered two, three or four times daily, i.e. in two, three or four batches in a 24 hour period (on two, three or four occasions in a 24 hour period).
  • the physician or the skilled person, will be able to determine the actual dosage which will be most suitable for an individual patient, which is likely to vary with the route of administration, the type and severity of the condition that is to be treated, as well as the species, age, weight, sex, renal function, hepatic function and response of the particular patient to be treated.
  • the above-mentioned dosages are exemplary of the average case; there can, of course, be individual instances where higher or lower dosage ranges are merited, and such are within the scope of this invention.
  • the dose of medicament is administered more than once daily, then the quantity given on each occasion may or may not be divided equally. For instance, if the total daily dose should be 100 mg (which is typically the lower limit of the total daily dose), and the administration method requires twice daily oral intake, then each dose may be 50 mg each or, equally, one dose may be 75 mg and the second dose may be 25 mg.
  • the actual quantity of the medicament administered to the patient on each occasion, and the frequency of administration, will depend on the disease or condition to be treated (and on the patient himself).
  • the device of the invention allows (or alerts) the patient or user to take the appropriate dose on the relevant number of occasions (e.g.
  • each unit of medicine contains from approximately 20% to 2% of the weight of the total dose to be administered on each specific occasion.
  • the medicament may consist of several individual units, i.e. partial doses (e.g. tablets or capsules) contained within the device of the invention, and the total number of units to be administered on a single occasion may be 5 to 50 individual units.
  • the total number of individual units to be taken daily may be 5 (x the number of occasions) to 50 (x the number of occasions), i.e. when the units are taken on three occasions daily, then 15 to 150 individual units may be administered in that 24 hour period.
  • any number of individual units may be taken on a given occasion, provided that the total daily dose is respected. For instance, if the total daily dose of the medicament is 100 mg (which is typically the lower limit of the total daily dose), and it has to be taken once daily, then this may consist of 5 individual units of 20 mg taken on that one occasion. If the daily dose is taken on 2 occasions, and the dose is administered as 10 individual units, each unit being 10 mg, then this may be taken on two occasions (i.e. in two batches) in a 24 hour period, which may be 1 to 9 units (e.g. 4 to 6) on the first occasion and 9 to 1 (e.g. 6 to 4) units on the second occasion, making the total 10 units, thereby making up the total daily dose.
  • the total daily dose of the medicament is 100 mg (which is typically the lower limit of the total daily dose), and it has to be taken once daily, then this may consist of 5 individual units of 20 mg taken on that one occasion.
  • the daily dose is taken on 2 occasions, and the dose is administered as 10 individual units, each
  • a quantity of medicament taken on one occasion refers to the intake of a medicament within a period of less than 30 minutes, preferably less than 10 minutes and most preferably less than 5 minutes (e.g. less than 2 minutes).
  • the number of occasions that a daily dose is administered is greater than one in a 24 hour period, then the number of occasions may be spread out over the 24 hour period appropriately, such that there is preferably anywhere between 6 and 18 hours between each occasion. This is especially the case when the number of occasions per day is 2, 3 or 4.
  • the number of occasions may be spread out evenly over a period of 24 hours, i.e. it is most preferably 24 divided by the number of occasions.
  • the second dose is preferably about 8 and 16 hours after the first, and most preferably about 12 hours after the first).
  • the quantity of medicament taken on each occasion may or may not be divided equally between those number of occasions.
  • the quantity of medicament in a daily dose may be divided up equally (i.e. daily dose divided by the number of occasions; hence 100 mg daily may be administered in two 50 mg batches in 24 hours), or about equally (i.e. within a variation of less than 50%, preferably less than 25%, e.g.
  • a total of 100 mg taken twice daily may be administered in one batch of ⁇ 75 mg and >25 mg, preferably ⁇ 62.5 mg and >37.5 mg, e.g. ⁇ 55 mg and >45 mg, with the second batch making up the total daily dose), by the number of occasions (if greater than once daily) on which the medicament is taken in that 24 hour period.
  • the disease or condition that may be treated by the method (or regime) of the invention includes:
  • an impacter in the form of a rigid element fixedly connected at or towards one end to a wall of the storage chamber results in a means for agitating units of medicine stored within the storage chamber that requires minimal space in an outward direction to operate. It therefore allows the amount of useful storage space within the dosing and dispensing device in percentage terms to be maximized.
  • the storage chamber is preferably provided in a removable cassette that is releasably engageable within the housing.
  • the cassette and the housing preferably include mutually engageable latch members that interengage on insertion of the cassette into the housing to retain the cassette within the housing.
  • the dosing and dispensing device also preferably includes an ejection mechanism that is selectively operable to disengage the latch members and allow removal of the cassette from the housing.
  • the cassette and housing can be formed such that any outer surfaces of the cassette are flush with adjacent outer surfaces of the housing when the cassette is inserted into the housing, which enhances the outer appearance of the dosing and dispensing device.
  • a medicament for use in the treatment of a disease wherein the medicament is orally administered on one to ten occasions daily using a hand held medicine dosing and dispensing device
  • the hand held medicine dosing and dispensing device comprises a housing including a storage chamber to store discrete units of medicine; and a feed assembly located between the storage chamber and a dispenser to feed individual units of medicine from the storage chamber to the dispenser
  • the storage chamber is provided in a removable cassette that is releasably engageable within the housing and characterised in that the cassette and the housing include mutually engageable latch members that engage on insertion of the cassette into the housing to retain the cassette within the housing
  • the dosing and dispensing device further includes an ejection mechanism that is selectively operable to disengage the latch members and allow removal of the cassette from the housing.
  • the medicament, disease and administration method are as hereinbefore defined.
  • the ejection mechanism may be adapted so that it is only operable to disengage the latch members and allow removal of the cassette from the housing when the storage chamber of the cassette is empty.
  • the provision of a cassette having outer surfaces that are flush with adjacent outer surfaces of the housing when the cassette is inserted into the housing may reduce the risk of someone being able to force the cassette out of the housing in order to gain unauthorized access to the units of medicine.
  • the dosing and dispensing device preferably includes one or more sensors.
  • One of the cassette and the housing may include latch members in the form of elongate projections engageable, when the cassette is received within the housing, with latch members in the form of corresponding openings provided in the other of the cassette and the housing.
  • the dosing and dispensing device preferably includes one or more biasing members to bias each of the elongate projections into engagement with the corresponding opening when the cassette is received within the housing.
  • the dispenser includes a dispensing chamber to collect and hold individual units of medicine fed from the storage chamber via the feed assembly, the dispensing chamber including a dispensing outlet selectively openable to dispense units of medicine held in the dispensing chamber.
  • the dispensing chamber may be movable between a first position in which the dispensing outlet is closed and a second position in which the dispensing outlet is open.
  • the dispenser may further include a motor to effect movement of the dispensing chamber between its first and second positions.
  • the dispenser may omit the dispensing chamber and the feed assembly may communicate directly with a dispensing outlet.
  • the feed assembly preferably includes a feed wheel defining a plurality of feed pockets about its circumference.
  • the feed wheel is rotatable in a first direction to move the feed pockets sequentially into alignment with a feed channel of the storage chamber to each receive a unit of medicine.
  • the feed pockets are moved sequentially into alignment with the dispenser so as to feed the received units of medicine sequentially to the dispenser.
  • the feed wheel is preferably located in the cassette.
  • the dispenser may also form part of the cassette, the feed wheel being located between the storage chamber and the dispenser, and thereby also minimizing the risk of the introduction of contaminants into the dispenser during replacement of the cassette.
  • the dosing and dispensing device preferably includes a motor to drive the feed wheel, the drive motor preferably being controllable to drive the feed wheel to rotate in the first direction so as to feed a predetermined number of units to the dispenser.
  • the drive motor also preferably forms part of the ejection mechanism and is controllable to drive the feed wheel to rotate in a second direction to disengage the latch members and allow removal of the cassette from the housing.
  • the feed wheel may include a drive shaft and the drive motor may include a drive gear engageable with an end of the drive shaft.
  • the end of the drive shaft defines a pair of sloped contact surfaces, each contact surface terminating in a shoulder against which the drive gear engages on rotation in a first direction and the sloped contact surfaces defining cam surfaces along which the drive gear travels causing movement of the cassette relative to the housing on rotation of the drive motor in the second direction to disengage the latch members.
  • the dosing and dispensing device may further include a biasing member to expel the cassette on disengagement of the latch members.
  • the feed wheel defines the actuating mechanism and the impacter is operably associated at or towards its second end with the feed wheel.
  • the feed wheel may include a plurality of equidistantly spaced fins protruding outwards from its outer circumference, adjacent fins defining the feed pockets therebetween. Rotation of the feed wheel in the first direction moves each of the fins sequentially into engagement with a front face of the second end of the impacter. Continued rotation of the feed wheel causes deflection of the second end of the impacter towards the wall of the storage chamber as the respective fin is moved across the front face of the second end of the impacter and out of engagement therewith.
  • This arrangement effects the movement required to cause repeated agitation of the units of medicine stored in the storage chamber during dispensing of a number of units of medicine and therefore assists in ensuring that units of medicine stored in the storage chamber do not form a bridge during dispensing. It therefore assists in improving the efficiency of the dosing and dispensing device.
  • rotation of the feed wheel in the second direction preferably moves an adjacent one of the fins into engagement with a second face of the second end of the impacter such that the second end of the impacter blocks further rotation of the feed wheel in the second direction.
  • the impacter may be formed from a magnetic material and the actuating mechanism may include an electro-magnet selective operable to cause deflection of the second end of the impacter towards the wall of the storage chamber.
  • the dosing and dispensing device preferably includes a controller to control operation of the dosing and dispensing device, and such controller preferably being programmable to prompt a user to activate the dosing and dispensing device to dispense a predetermined number of units of medicine at one or more predetermined times.
  • the dosing and dispensing device may includes a display to display information to a user, which allows the dosing and dispensing device to display, for example, time, medication and/or dosage size.
  • the dosing and dispensing device also preferably includes a data input device to enter data into the controller and effect operation of the dosing and dispensing device in accordance with the input data.
  • a data input device allows a user to influence operation of the dosing and dispensing device in dependence on the user's symptoms, for example.
  • the display and the data input device are provided in the form of a touch-sensitive screen.
  • a visual analogue scale may be selectively displayed on the screen to facilitate the input of data, and the visual analogue scale (VAS) may be displayed on the screen when the dosing and dispensing device dispenses one or more units of medicine.
  • the dosing and dispensing device includes a memory to store times of dosing and dose sizes provided and thereby maintain an electronic log function. This in turn can be used to monitor dosage compliance.
  • the dosing and dispensing device may not necessarily require the provision of an input device.
  • the dosing and dispensing device may include a settable alarm that emits sound or light, and/or causes the dispensing device to vibrate at one or more predetermined times. This helps to ensure that the user dispenses the required number of units of medicine and takes his or her dose of the medicine within the therapeutic window associated with the medicine.
  • the dosing and dispensing device may include a lock. This reduces the risk of children, for example, dosing and dispensing units of medicine from the dispensing device.
  • the cassette may include a readable marker and a controller in the device may include a reader to read the marker on the cassette and thereby allow the controller to identify the medicine contained in the cassette.
  • This arrangement permits the controller to be pre-programmed to function in a number of predetermined modes of operation, each mode of operation being specific to a particular medicine, and to then select the mode of operation applicable to the medicine contained in the cassette once it has identified the medicine contained in the cassette.
  • a hand held medicine dosing and dispensing device 10 according to an embodiment of the invention is shown in Figures 2 and 3 .
  • the dosing and dispensing device 10 is comparable in size with other hand held devices such as, for example, mobile telephones, thereby rendering the dosing and dispensing device 10 suitable for use as a hand held device. It is envisaged that in other embodiments the size and shape of the dosing and dispensing device 10 may be varied to render the dosing and dispensing device 10 suitable for users having limited dexterity, for example.
  • the dosing and dispensing device 10 includes a housing 12 including a storage chamber 14 to store discrete units of medicine 16 and a feed assembly 18 located between the storage chamber 14 and a dispenser 20.
  • the dosing and dispensing device 10 also includes an impacter 22 ( Figure 4 ) that is operably associated with the storage chamber 14 to agitate units of medicine 16 stored in the storage chamber 14.
  • the impacter 22 includes a rigid element 24 fixedly connected at one end 26 to a wall 28 of the storage chamber 14.
  • the impacter 22 is operably associated at a second end 30 with an actuating mechanism 32 that deflects the second end 30 of the impacter 22 towards the wall 28 of the storage chamber 14 to strain the impacter 22 such that, when released, the strained impacter 22 moves towards the interior 34 of the storage chamber 14 and impacts again units of medicine 16 stored therein.
  • the dosing and dispensing device 10 includes a storage chamber 14 provided in a removable cassette 36 that is releasably engageable with the housing 12.
  • the storage chamber 14 may be permanently located within the housing 12, the housing 12 including an opening to permit access to the storage chamber 14 to permit refilling thereof.
  • the housing 12 and cassette 36 include mutually engageable latch members that interengage on insertion of the cassette 36 into the housing 12 to retain the cassette 36 within the housing 12.
  • the dosing and dispensing device 10 also includes an ejection mechanism that is selectively operable to disengage the latch members and allow removal of the cassette 36 from the housing 12.
  • the latch members include elongate projections 42 provided on an upper face 44 of the cassette 36 and extending in the direction in which the cassette 36 is inserted into and withdrawn from the housing 12.
  • the latch members also include correspondingly shaped and sized openings 46 ( Figures 9 and 10 ) provided on an inner surface 48 of an upper face 50 of the housing 12.
  • the openings 46 are located on the inner surface 48 so as to be aligned with the projections 42 provided on the cassette 36. Accordingly, when the cassette 36 is fully inserted into the housing 12, the elongate projections 42 are received within the respective openings 46. This engagement prevents sliding withdrawal of the cassette 36 from the housing 12.
  • first and second leaf springs 52a,52b are provided on an inner surface 54 of the lower face 56 of the housing 12.
  • the first and second leaf springs 52a,52b are located within an internal cavity 58 of the housing 12 in which the cassette 36 is received and act on the cassette 36 to bias the cassette 36 towards the inner surface 48 of the upper face 50 of the housing 12.
  • the leaf springs 52a,52b thereby bias the projections 42 into engagement with the respective openings 46.
  • each of the projections 42 On insertion of the cassette 36 into the internal cavity 58 of the housing 12, a leading end face 60 of each of the projections 42 contacts the inner surface 54 of the lower face 56 of the housing 12. To assist sliding movement of this leading end 60 over the inner surface 54, the leading end 60 of each projection 42 is beveled as shown in Figures 11 and 12 .
  • the leading end 60 engages the respective opening 46 in the inner surface 48 of the upper face 50 of the housing 12, this engagement serving to guide and locate the remainder of the projection 42 into the respective opening 46. Consequently, as well as acting to retain the cassette 36 within the housing 12, engagement of the projections 42 in the openings 46 during insertion of the cassette 36 into the housing 12 acts to guide and locate the cassette 36 in the internal cavity 58 of the housing 12.
  • a spring support 62 ( Figure 9 ) provided on an end wall 64 of the cassette 36 engages against an engagement surface 66 of a biasing member 68, which is moveably mounted on the inner surface 48 of the upper face 50 of the housing 12.
  • the biasing force provided by the coiled spring located within the biasing member 68 may be adjusted by adjusting the degree of compression present within the coiled spring prior to engagement of the spring support 62 against the engagement surface 66.
  • the greater the degree of compression present in the coiled spring prior to such engagement the greater the biasing force provided on engagement of the spring support 62 against the engagement surface 66, and vice versa. This is advantageous in that it allows adjustment of the force applied to the cassette 36 during ejection of the cassette 36 from the housing 12, which is described below.
  • the dispenser 20 includes a dispensing chamber 72 ( Figures 12A and 12B ) to collect and hold individual units of medicine 16 from the storage chamber 14 via the feed assembly 18.
  • the dispensing chamber 72 includes a dispensing outlet 74 that is selectively openable to dispense units of medicine 16 held in the dispensing chamber 72.
  • the dispenser 20 forms part of the cassette 36 and the dispensing chamber 72 is movable between a first position ( Figure 12A ) in which the dispensing outlet 74 is closed and a second position ( Figure 12B ) in which the dispensing outlet 74 is open.
  • the dispensing outlet 74 is aligned with a base wall 76 of the cassette 36, the base wall 76 thereby closing the dispensing outlet 74.
  • the dispensing outlet 74 is aligned with an opening 78 provided in the base wall 76 of the cassette 36, the opening 78 thereby opening the dispensing outlet 74.
  • Movement of the dispensing chamber 72 between its first and second positions is effected by means of a first drive motor 80 ( Figure 10 ) that is operable to drive linear movement of a drive member 82 ( Figures 9 and 10 ) in first and second directions.
  • the drive member 82 defines a recess 84 at a free end 86 to receive a peg 88 protruding from the dispensing chamber 72 through a slot 90 provided in a side wall 92 of the cassette 36.
  • movement of the drive member 82 causes movement of the peg 88 from one end of the slot 90 to the other and back, and thereby results in movement of the dispensing chamber 72 from its first position to its second position and back to its first position.
  • the dispenser 20 may not include a dispensing chamber 72, and the feed assembly 18 may feed the units of medicine 16 direct to a permanently open dispensing outlet 74 of the dispenser 20.
  • the feed assembly 18 includes a feed wheel 94 ( Figure 4 ) defining a plurality of feed pockets 96 about its circumference.
  • the feed wheel 94 is located in the cassette 36 between the storage chamber 14 and the dispenser 20.
  • the feed wheel 94 is mounted to rotate so that rotation in a first direction, which is depicted by arrow A in Figure 4 , moves the feed pockets 96 sequentially into alignment with a feed channel 98 of the storage chamber 14 to each receive a unit of medicine 16.
  • the feed pockets 96 are moved sequentially into alignment with an inlet of the dispensing chamber 72 of the dispenser 20 to feed the respective units of medicine 16 into the dispensing chamber 72 dispenser 20.
  • the dosing and dispensing device 10 includes a second drive motor 100 ( Figures 9, 10 , 13 and 14 ) to drive the feed wheel 94 to rotate, the second drive motor 100 being mounted on the inner surface 48 of the upper face 50 of the housing 12.
  • a drive gear 102 ( Figure 13 ) engages a drive shaft 104 ( Figures 11 , 12A and 12B ) that protrudes from the upper face 44 of the cassette 36.
  • the drive shaft 104 is formed to define sloped edges 106,108 that terminate in shoulders 110,112 ( Figures 12A and 12B ).
  • the drive gear 102 includes an elongate lug 114 that engages the shoulders 110,112 and, on rotation of the second drive motor 100 in a first direction, drives the drive shaft 104 to rotate. This in turn causes the feed wheel 94 to rotate in the first direction.
  • the second drive motor 100 includes electrical contacts 116. These electrical contacts 116 engage corresponding contacts (not shown) on the cassette 36 on insertion of the cassette 36 into the internal cavity 58 of the housing 12.
  • the drive shaft 104 is operable by hand to effect rotation of the feed wheel 94 in the first direction when the cassette 36 is removed from the housing.
  • Such operation allows a user to feed units of medicine 16 from the storage chamber 14 of the cassette 36 in the event, for example, that a fault occurs within the dosing and dispensing device 10 that prevents a user from operating the dosing and dispensing device 10 to prepare and dispense a dose of the medicine contained within the storage chamber 14.
  • the drive shaft 104 may be locked against manual rotation so that units of medicine 16 may only be accessed when the cassette 36 is mounted within the housing 12 of the dosing and dispensing device 10.
  • the cassette 36 may also be sealed so as to prevent unauthorized access to any units of medicine 16 stored in the storage chamber 14 of the cassette 36.
  • the dosing and dispensing device 10 also includes a sensor in the form of a photocell 117 ( Figure 14 ) arranged relative to the inlet of the dispensing chamber 72 to detect movement of units of medicine 16 from feed pockets 96 of the feed wheel 94 into the dispensing chamber 72.
  • a sensor in the form of a photocell 117 ( Figure 14 ) arranged relative to the inlet of the dispensing chamber 72 to detect movement of units of medicine 16 from feed pockets 96 of the feed wheel 94 into the dispensing chamber 72.
  • the sensor monitors the movement of units of medicine 16 moving from the feed pockets 96 of the feed wheel 94 into the dispensing chamber 72.
  • the information provided by the sensor allows movement of the second drive motor 100 to be controlled to drive the feed wheel 94 in the first direction so as to feed a predetermined number of units of medicine 16 to the dispenser 20.
  • the sensor also allows the dosing and dispensing device 10 to determine when the storage chamber 14 is empty.
  • the second drive motor 100 drives the feed wheel 94 to rotate so as to feed units of medicine 16 from the storage chamber 14 of the cassette 36, via the feed pockets 96, to the dispensing chamber 72.
  • the photocell 117 is located relative to the inlet of the dispensing chamber 72 so as to enable the dosing and dispensing device 10 to be able to determine the number of units of medicine 16 that are fed into the dispensing chamber 72.
  • the second drive motor 100 is controlled to continue to drive rotation of the feed wheel 94 until the dosing and dispensing device 10 determines via the photocell 117 that the required number of units of medicine 16 have been fed into the dispensing chamber 72, at which point the second drive motor 100 stops driving rotation of the feed wheel 94.
  • This arrangement means that the feed wheel 94 continues to turn to deliver units of medicine 16 into the dispensing chamber 72 until the required number of units of medicine 16 is fed into the dispensing chamber 72. It thereby ensures that the required number of units of medicine 16 is fed into the dispensing chamber 72 regardless of whether or not one of the feed pockets 96 fails to receive and feed a unit of medicine 16 from the storage chamber 14 to the dispensing chamber 72 during rotation of the feed wheel 94.
  • the dosing and dispensing device 10 determines that the storage chamber 14 is empty.
  • the dosing and dispensing device 10 determines that the storage chamber 14 is empty if the photocell 117 identifies more than six consecutive empty feed pockets 96 being aligned with the inlet of the dispensing chamber 72 during rotation of the feed wheel 94.
  • the predetermined number of consecutive empty feed pockets required to determine whether the storage chamber 14 is empty may increase or decrease.
  • the second drive motor 100 may be driven in a second, opposite, direction.
  • Rotation of the second drive motor 100 in the opposite direction causes the lug 114 to travel along the sloped edges 106,108 on the drive shaft 104. Since the drive gear 102 is fixe d relative to the upper face 50 of the housing 12, movement of the lug 114 along the sloped edges 106,108 causes movement of the cassette 36 away from the inner surface 48 of the upper face 50 of the housing 12. This movement in turn moves the projections 42 out of engagement with the openings 46 and the bias provided by the compressed spring located within the biasing member 68 pushes the cassette 36 in an outward direction and thereby ejects the cassette 36 from the housing 12.
  • a user may insert a replacement cassette 36 into the dosing and dispensing device 10 in order to replenish or change the supply of medicine contained within the dosing and dispensing device 10.
  • the second drive motor 100 may only be driven in the second, opposite, direction once the sensors have determined that the storage chamber 14 of the cassette 36 is empty. In such embodiments, controlled operation of the ejection mechanism prevents unauthorized or otherwise illegitimate access to the units of medicine 16 stored within the storage chamber 14 of the cassette 36.
  • an external surface 38 of the cassette 36 that is flush with the adjacent outer surface 40 of the housing 12 is advantageous in that it reduces the possibility of someone seeking to prise the cassette 36 out of the housing 12.
  • the feed wheel 94 defines the actuating mechanism 32 with which the second end 30 of the impacter 22 is operably associated.
  • the feed wheel 94 includes a plurality of equidistantly spaced fins 118 protruding outwardly from its outer circumference, adjacent fins 118 defining the feed pockets 96 therebetween.
  • each of the fins 118 is such that rotation of the feed wheel 94 in the first direction moves each of the fins 118 sequentially into engagement with a front face 120 of the second end 30 of the impacter 22, as shown in Figure 5 .
  • Continued rotation of the feed wheel 94 causes deflection of the second end 30 of the impacter 22 towards the wall 28 of the storage chamber 14 as the respective fin 118 is moved across the front face 120 ( Figures 6 and 7 ) until the fin 118 moves out of engagement with the second end 30 of the impacter 22 ( Figure 8 ).
  • the strained impacter 22 moves towards the interior 34 of the storage chamber 14 and impacts against units of medicine 16 stored therein.
  • each fin 118 that contacts the second end 30 of the impacter 22 is shaped so as to present a curved face 122 to the front face 120 of the second end 30 of the impacter 22 so as to facilitate movement over the front face 120.
  • the curved face 122 terminates in a shoulder 124 that is brought into engagement with a rear face 126 of the second end 30 of the impacter 22 in the event the feed wheel 94 is driven to rotate in a second, opposite, direction.
  • This engagement together with the relative positions of the second end 30 of the impacter 22 and the free end of the fin 118 when the impacter 22 is in its unstrained condition means that the second end 30 of the impacter 22 blocks further rotation of the feed wheel 94 in the second direction.
  • movement of the second end 30 of the impacter 22 towards the wall 28 of the storage chamber 14 may be effected by other means.
  • the impacter 22, or at least the second end 30 of the impacter 22, is formed from, or coated with, a magnetic material and an electro-magnet is provided in the storage chamber 14.
  • the magnetic field produced by the electro-magnet causes deflection of the second end 30 of the impacter 22 towards the wall 28 of the storage chamber 14 so as to strain the impacter 22.
  • the electro-magnet may be mounted on the wall 28 of the storage chamber 14 and the magnetic field produced by the electro-magnet may attract the second end 30 of the impacter 22 towards the wall 28 of the storage chamber 14.
  • the second end 30 of the impacter 22 is released, allowing the strained impacter 22 to move towards the interior 34 of the storage chamber 14, on removal of the current to the electro-magnet.
  • the dosing and dispensing device 10 includes a separating element 128 located above the feed wheel 94 and adjacent the impacter 22 so as to prevent units of medicine 16 becoming jammed between a feed pocket 96 in the feed wheel 94 already containing a unit of medicine 16 and the impacter 22.
  • the separating element 128 presents a sloped face 130 towards the interior 34 of the storage chamber 14 so as to direct the units of medicine towards the feed channel 98 of the storage chamber 14.
  • the separating element 128 also presents a curved face 132 to the feed wheel 94 so as to allow the tips of the fins 118 to travel past the separating element 128.
  • the dosing and dispensing device 10 shown in Figures 2 and 3 includes a programmable controller to prompt a user to dispense units of medicine 16 at one or more pre-determined times throughout the day.
  • the controller activates an alarm provided in the dosing and dispensing device 10 to emit sound or light and/or causes the dosing and dispensing device 10 to vibrate so as to alert the user to dispense units of medicine 16 and take his or her dose of the medicine within a therapeutic window associated with the medicine.
  • the controller may be programmed to emit one or more further alarms within a predetermined time from the first alarm.
  • a message delivered on a display 134 provided on an outer surface 136 of the upper face 50 of the housing 12 prompts the user to enter a code into the dosing and dispensing device 10 via a data input device.
  • the display 134 is provided in the form of a touch-sensitive screen, which also functions as the data input device.
  • the dosing and dispensing device 10 On entry of the correct code, the dosing and dispensing device 10 is unlocked and a message delivered on the display 134 prompts the user to activate the dosing and dispensing device 10 to feed either a predetermined number of units of medicine 16 into the dispensing chamber 72 or prompts the user to identify the dose of medicine he or she requires.
  • the data input device may be provided in the form of a keypad mounted on the outer surface 136 of the upper face 50 of the housing 12.
  • the lock may be omitted.
  • the controller operates the second drive motor 100 to operate the feed wheel 94 to feed the number of units of medicine 16 into the dispensing chamber 72 that will provide the required dose of medicine to the user.
  • a sensor preferably provided in the form of a photocell, senses the movement of each unit of medicine 16 that passes from the feed wheel 94 into the dispensing chamber 72. This allows the controller to count the number of units of medicine 16 that are fed into the dispensing chamber 72.
  • the controller ceases operation of the second drive motor 100 and thereby ceases operation of the feed wheel 94.
  • the first motor 80 is then operated to cause movement of the dispensing chamber 72 from its first position to its second position so as to open the dispensing outlet 74 of the dispenser 20 and dispense the dose of medicine held in the dispensing chamber 72 to the user.
  • the dosing and dispensing device 10 will automatically feed a predetermined number of units of medicine 16 to the dispensing chamber 72 once the dosing and dispensing device 10 is unlocked.
  • the controller may display further messages before, during or after operation of the second drive motor 100 to prompt the user to respond to questions concerning the nature of any symptoms he or she may be experiencing via the data input device.
  • VAS visual analogue scale
  • the information provided by the patient to the questions posed, via the data input device, is stored within a memory provided in the dosing and dispensing device 10 and may be accessed on the display 134 of the dosing and dispensing device 10 or by connecting the dosing and dispensing device 10 to a computer via a USB port, for example.
  • This facility allows a user and his or her physician to monitor the user's symptoms at the time of drug intake, for example, which may be particularly beneficial for the user and the physicial in the dose-finding process.
  • the memory provided in the dosing and dispensing device 10 may record the times at which the dosing and dispensing device 10 is activated to prepare a dose of medicine and dispense that dose. It may also record the dose prepared and dispensed each time in terms of the number of units of medicine 16. This information provides an electronic log, which may be accessed by connecting the dosing and dispensing device 10 to a computer, and provides a means for monitoring dosage compliance.
  • the cassette 36 includes a readable marker (not shown) identifying the medicine contained within the storage chamber 14 of the cassette 36.
  • a reader provided within the inner cavity 58 of the housing 12 of the dosing and dispensing device 10 reads the readable marker is read on insertion of the cassette 36 into the inner cavity 58, and allows the controller within the dosing and dispensing device 10 to identify the medicine.
  • the controller may be programmed to function in a number of predetermined modes of operation, each mode of operation being specific to a particular medicine, and to then select the mode of operation applicable to the medicine contained in the cassette 36 once it has identified the medicine contained in the cassette 36.
  • the provision of a readable marker is advantageous in circumstances where there are insufficient units of medicine contained within a cassette to allow the dosing and dispensing device 10 to feed the required number of units of medicine 16 to the dispensing chamber 72 in a single operation.
  • the dispensing outlet 74 of the dispenser 20 may be opened to dispense the units of medicine 16 held in the dispensing chamber 72 and the empty cassette 36 is replaced with a replacement cassette 36.
  • the controller may check that the replacement cassette 36 contains the same medicine before operating the second drive motor 100 to continue to feed the units of medicine 16 to the dispensing chamber 72 required to complete the dose.
  • the display 134 displays a message to the user clearly identifying that the units of medicine 16 dispensed from the dispensing chamber 72 prior to replacement of the empty cassette 36 is an incomplete dose.
  • the dispenser 20 forms part of the housing 12 instead of the cassette 36.
  • the location of the dispensing chamber 72 in the housing 12 renders it unnecessary for an incomplete dose to be dispensed prior to replacement of an empty cassette 36.
  • the number of units of medicine 16 to be dispensed from the dosing and dispensing device 10 is determined by the size of the total dose required and is therefore determined by the amount of active ingredient or medicine contained in each unit of medicine 16.
  • the amount of active ingredient contained in each unit of medicine 16 may be chosen depending on the nature of the medicine and the side effects that arise from over or under dosing. For example, the amount of active ingredient contained in each unit of a medicine for which the side effects arising from over or under dosing are minimal may be greater than that for a medicine for which the side effects are more pronounced. This is because the greater the amount of active ingredient contained in each unit of medicine, the less possible it is to fine tune the total dose.
  • each unit of medicine contains from approximately 20% to 2% of the weight of the total dose to be administered and dispensed from the dosing and dispensing device 10 at any one time.
  • the units of medicine may be provided in the form of tablets or pellets, and preferably have convex or iso-diametrical surfaces so as to define a spherical or near spherical shape produced through the use of a punch having a concave surface.
  • the tablets preferably have a diameter in the range of 1-13mm, more preferably in the range of 2-8mm and most preferably in the range of 2-5mm.
  • the pellets preferably have a size in the range of 1-8mm and most preferably in the range of 1-4mm.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mechanical Engineering (AREA)
  • Medical Informatics (AREA)
  • Medicinal Preparation (AREA)

Claims (15)

  1. Dispositif portable de dosage et de distribution de remède (10) comprenant un boîtier (12) incluant un compartiment de stockage (14) contenant des unités discrètes de remède (16) ; un ensemble d'alimentation situé entre le compartiment de stockage et un distributeur (20) destiné à acheminer les unités individuelles de remède du compartiment de stockage vers le distributeur ; et un percuteur (22) lié de manière fonctionnelle au compartiment de stockage pour agiter les unités de remède stockées dans le compartiment de stockage, caractérisé en ce que le percuteur inclut un élément rigide (24) relié de manière fixe, près ou en direction d'une extrémité (26), à une paroi du compartiment de stockage et lié de manière fonctionnelle, près ou en direction d'une deuxième extrémité (30), à un mécanisme d'actionnement (32) qui infléchit la deuxième extrémité du percuteur vers la paroi du compartiment de stockage afin de contraindre le percuteur de sorte que, lorsqu'il est libéré, le percuteur contraint se déplace vers l'intérieur du compartiment de stockage et percute les unités de remède ;
    le compartiment de stockage étant formé dans une cassette (36) amovible qui peut être engagée de manière réversible dans le boîtier et les unités de remède comprenant un médicament qui est ou contient de la lévodopa/carbidopa ou du lévodopa/bensérazide, de la morphine, de l'oxicodone ou de la méthadone, de la prégabaline, du diazépam, de l'oxazépam ou de l'alprazolam, de l'acarbose, de la metformine, du glibenclamide ou du glipizide, de l'atomoxétine, de la capécitabine, de la pyridostigmine, de la warfarine, du valproate ou de la quétiapine.
  2. Cassette (36) configurée pour pouvoir être engagée de manière réversible avec un dispositif portable de dosage et de distribution de remède (10), la cassette comprenant un compartiment de stockage (14), un ensemble d'alimentation situé entre le compartiment de stockage et un distributeur (20) destiné à acheminer les unités individuelles de remède du compartiment de stockage vers le distributeur ; et un percuteur (22) lié de manière fonctionnelle au compartiment de stockage pour agiter les unités de remède stockées dans le compartiment de stockage, caractérisée en ce que le percuteur comporte un élément rigide (24) relié de manière fixe, près ou en direction d'une extrémité (26), à une paroi du compartiment de stockage et lié de manière fonctionnelle, près ou en direction d'une deuxième extrémité (30), à un mécanisme d'actionnement (32) qui infléchit la deuxième extrémité du percuteur vers la paroi du compartiment de stockage afin de contraindre le percuteur de sorte que, lorsqu'il est libéré, le percuteur contraint se déplace vers l'intérieur du compartiment de stockage et percute les unités de remède ;
    les unités de remède comprenant un médicament qui est ou contient de la lévodopa/carbidopa ou du lévodopa/bensérazide, de la morphine, de l'oxicodone ou de la méthadone, de la prégabaline, du diazépam, de l'oxazépam ou de l'alprazolam, de l'acarbose, de la metformine, du glibendamide ou du glipizide, de l'atomoxétine, de la capécitabine, de la pyridostigmine, de la warfarine, du valproate ou de la quétiapine.
  3. Dispositif portable de dosage et de distribution de remède (10) selon la revendication 1 ou cassette (36) selon la revendication 2, incluant en outre un ou plusieurs capteurs pour détecter quand le compartiment de stockage est vide.
  4. Dispositif portable de dosage et de distribution de remède ou cassette selon l'une quelconque des revendications précédentes, incluant un compartiment de distribution (72) destiné à collecter et à contenir les unités individuelles de remède provenant du compartiment de stockage via l'ensemble d'alimentation, le compartiment de distribution incluant un orifice de distribution (74) susceptible d'être ouvert de manière sélective afin de distribuer des unités de remède contenues dans le compartiment de distribution.
  5. Dispositif portable de dosage et de distribution de remède ou cassette selon la revendication 4, dans lequel/laquelle le compartiment de distribution (72) est mobile de manière sélective entre une première position dans laquelle l'orifice de distribution (74) est fermé et une seconde position dans laquelle l'orifice de distribution (74) est ouvert.
  6. Dispositif portable de dosage et de distribution de remède selon la revendication 5, dans lequel le distributeur (20) inclut en outre un moteur pour déplacer le compartiment de distribution entre sa première et sa seconde position.
  7. Dispositif portable de dosage et de distribution de remède ou cassette selon l'une quelconque des revendications précédentes, dans lequel/laquelle l'ensemble d'alimentation inclut une roue d'alimentation (94) définissant une pluralité de poches d'alimentation (96) sur sa circonférence, la roue d'alimentation (94) pouvant tourner dans une première direction pour déplacer séquentiellement les poches d'alimentation (96) de manière à les aligner avec un canal d'alimentation (98) du compartiment de stockage, afin que chacune reçoive une unité de remède (16), et la poursuite de la rotation de la roue d'alimentation (94) dans la première direction ayant pour effet de déplacer séquentiellement les poches d'alimentation (96) de manière à les aligner avec le distributeur (20), afin d'alimenter séquentiellement le distributeur avec les unités de remède reçues.
  8. Dispositif portable de dosage et de distribution de remède ou cassette selon la revendication 7, dans lequel/laquelle la roue d'alimentation (94) est située dans la cassette (36).
  9. Dispositif portable de dosage et de distribution de remède selon l'une quelconque des revendications 4 à 6 et 8, dans lequel le distributeur (20) forme une partie de la cassette et la roue d'alimentation (94) est située dans la cassette (36) entre le compartiment de stockage et le distributeur (20).
  10. Dispositif portable de dosage et de distribution de remède selon l'une quelconque des revendications 7 à 9, incluant un moteur d'entraînement pour faire tourner la roue d'alimentation.
  11. Dispositif portable de dosage et de distribution de remède selon la revendication 10, dans lequel le moteur d'entraînement peut être commandé pour faire tourner la roue d'alimentation (94) dans la première direction de manière à acheminer un nombre prédéterminé d'unités vers le distributeur (20).
  12. Dispositif portable de dosage et de distribution de remède ou cassette selon l'une quelconque des revendications 1 et 7 à 11, dans lequel/laquelle la roue d'alimentation (94) définit le mécanisme d'actionnement (32) et le percuteur (22) est lié de manière fonctionnelle, près ou en direction de sa deuxième extrémité, à la roue d'alimentation.
  13. Dispositif portable de dosage et de distribution de remède ou cassette selon la revendication 12, dans lequel/laquelle la roue d'alimentation inclut sur sa circonférence une pluralité d'ailettes (118) équidistantes et orientées vers l'extérieur, les ailettes voisines définissant les poches d'alimentation (96) entre elles de sorte que la rotation de la roue d'alimentation (94) dans la première direction déplace séquentiellement chaque ailette (118) et l'engage dans une face avant de la deuxième extrémité du percuteur (22), la poursuite de la rotation de la roue d'alimentation (94) infléchissant la deuxième extrémité du percuteur (22) vers la paroi du compartiment de stockage lorsque l'ailette respective balaye la face avant de la deuxième extrémité du percuteur (22) jusqu'à se dégager de celle-ci.
  14. Dispositif portable de dosage et de distribution de remède ou cassette selon la revendication 13, dans lequel/laquelle une rotation de la roue d'alimentation dans la deuxième direction déplace une des ailettes (118) voisines et l'engage dans une deuxième face de la deuxième extrémité du percuteur (22), de sorte que la deuxième extrémité du percuteur (22) empêche la poursuite de la rotation de la roue d'alimentation dans la deuxième direction.
  15. Dispositif portable de dosage et de distribution de remède ou cassette selon l'une quelconque des revendications 1 à 11, dans lequel/laquelle le percuteur (22) est formé dans un matériau magnétique et le mécanisme d'actionnement (32) inclut un électro-aimant pouvant être commandé de manière sélective afin d'infléchir la deuxième extrémité du percuteur vers la paroi du compartiment de stockage.
EP15195229.8A 2010-06-02 2011-05-31 Nouveau procédé d'administration Active EP3002002B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1009237A GB2480835A (en) 2010-06-02 2010-06-02 A medication dispenser with an agitating element
EP11726702.1A EP2575737A1 (fr) 2010-06-02 2011-05-31 Nouveau procédé d'administration

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP11726702.1A Division EP2575737A1 (fr) 2010-06-02 2011-05-31 Nouveau procédé d'administration

Publications (2)

Publication Number Publication Date
EP3002002A1 EP3002002A1 (fr) 2016-04-06
EP3002002B1 true EP3002002B1 (fr) 2017-10-11

Family

ID=42471050

Family Applications (2)

Application Number Title Priority Date Filing Date
EP15195229.8A Active EP3002002B1 (fr) 2010-06-02 2011-05-31 Nouveau procédé d'administration
EP11726702.1A Ceased EP2575737A1 (fr) 2010-06-02 2011-05-31 Nouveau procédé d'administration

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP11726702.1A Ceased EP2575737A1 (fr) 2010-06-02 2011-05-31 Nouveau procédé d'administration

Country Status (5)

Country Link
EP (2) EP3002002B1 (fr)
DK (1) DK3002002T3 (fr)
ES (1) ES2652546T3 (fr)
GB (1) GB2480835A (fr)
WO (1) WO2011151056A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6195617B2 (ja) 2012-07-05 2017-09-13 ピー．シー．オー．エー． デバイシズ エルティーディー．Ｐ．Ｃ．Ｏ．Ａ． Ｄｅｖｉｃｅｓ Ｌｔｄ． 薬剤ディスペンサ
HUE034623T2 (en) 2012-07-30 2018-02-28 P C O A Devices Ltd Container for storing and dispensing solid drug pirates
CN103144900B (zh) * 2012-12-17 2015-12-23 苏州艾隆科技股份有限公司 针剂分配盒及具有其的针剂分配机
CN103144903B (zh) * 2012-12-17 2016-05-25 苏州艾隆科技股份有限公司 针剂分配盒及具有其的针剂分配机
WO2014107685A2 (fr) * 2013-01-04 2014-07-10 Insero Health Inc. Compositions et méthodes d'utilisation d'huperzine et de ses analogues
GB201301370D0 (en) 2013-01-25 2013-03-13 Sensidose Ab Dispensing device
CN103622975B (zh) * 2013-11-07 2016-06-15 广东药学院 格列吡嗪在制备治疗肿瘤药物中的应用
IL233295B (en) 2014-06-22 2019-11-28 Ilan Paz A control pill dispensing system
IL238387B (en) 2015-04-20 2019-01-31 Paz Ilan Drug dispenser release mechanism
ES2964750T3 (es) 2015-10-15 2024-04-09 DosentRX Ltd Dispensadores de formas de dosificación basados en reconocimiento de imágenes
WO2017077529A1 (fr) 2015-11-02 2017-05-11 P.C.O.A. Contenants de distribution de formes pharmaceutiques orales pouvant être avancés et verrouillés
US9731103B1 (en) 2017-01-13 2017-08-15 Berkshire Biomedical, LLC Computerized oral prescription administration devices and associated systems and methods
US10792226B2 (en) 2017-06-07 2020-10-06 Berkshire Biomedical, LLC Refill and dosage management devices and associated systems and methods for use with computerized oral prescription administration devices
US10588863B2 (en) * 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
JP6400169B1 (ja) * 2017-09-25 2018-10-03 株式会社バンダイ 収容物取出装置
US10441509B2 (en) 2018-03-16 2019-10-15 Berkshire Biomedical, LLC Computerized oral prescription administration with refillable medication dispensing devices and associated systems and methods
US10729860B1 (en) 2019-05-22 2020-08-04 Berkshire Biomedical, LLC Computerized oral prescription administration for securely dispensing a medication and associated systems and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0287335A3 (fr) 1987-04-14 1989-10-18 BAXTER INTERNATIONAL INC. (a Delaware corporation) Dispensateur de pillules avec moyens d'assistance à l'alimentation
SE516650C2 (sv) 1997-11-04 2002-02-05 Sensidos Ab Förfarande och anordning för dosering och dispensering av läkemedel
GB2465764A (en) * 2008-11-27 2010-06-02 Sensidose Ab Hand held medical dispensing device with agitating element

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
DK3002002T3 (en) 2018-01-08
ES2652546T3 (es) 2018-02-05
EP2575737A1 (fr) 2013-04-10
GB201009237D0 (en) 2010-07-21
EP3002002A1 (fr) 2016-04-06
WO2011151056A1 (fr) 2011-12-08
GB2480835A (en) 2011-12-07

Similar Documents

Publication Publication Date Title
EP3002002B1 (fr) Nouveau procédé d'administration
EP2367519B1 (fr) Dispositif de dosage et de distribution
US11484474B2 (en) Portable medication dispenser
EP2948390B1 (fr) Dispositif de distribution
US9642996B2 (en) Methods and apparatus for administering small volume oral transmucosal dosage forms
US7108153B2 (en) Apparatus, system, and method for a medication access control device
JP4629870B2 (ja) 自動型薬剤管理及び供給装置
US5564593A (en) Apparatus for dispensing medication
AU2311701A (en) Automated portable medication radial dispensing apparatus and method using a carrier type
CA2498496A1 (fr) Pilulier charge pour la distribution automatique de pilules d'ordonnance
JP2002502779A (ja) 計量小出し装置
JP2018504210A (ja) 医薬品包装および投与計画システム
GB2263068A (en) Inhalation device
US6237804B1 (en) Pill dispensing apparatus
Ferner et al. Coroner's cases of death due to errors in prescribing or giving medicines or to adverse drug reactions: Birmingham 1986–1991
EP3373913B1 (fr) Poudre compactée
JP2022506333A (ja) 薬剤ペレットのデリバリデバイス
US20220296537A1 (en) Novel pharmaceutical compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AC Divisional application: reference to earlier application

Ref document number: 2575737

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

17P Request for examination filed

Effective date: 20161006

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20170405

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AC Divisional application: reference to earlier application

Ref document number: 2575737

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 935389

Country of ref document: AT

Kind code of ref document: T

Effective date: 20171115

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602011042435

Country of ref document: DE

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20180104

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2652546

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20180205

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180111

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180112

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180111

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180211

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602011042435

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

26N No opposition filed

Effective date: 20180712

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20180531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

Ref country code: MK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171011

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20110531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171011

REG Reference to a national code

Ref country code: AT

Ref legal event code: UEP

Ref document number: 935389

Country of ref document: AT

Kind code of ref document: T

Effective date: 20171011

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20230427

Year of fee payment: 13

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230529

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20230517

Year of fee payment: 13

Ref country code: IE

Payment date: 20230424

Year of fee payment: 13

Ref country code: FR

Payment date: 20230523

Year of fee payment: 13

Ref country code: ES

Payment date: 20230607

Year of fee payment: 13

Ref country code: DK

Payment date: 20230427

Year of fee payment: 13

Ref country code: DE

Payment date: 20230510

Year of fee payment: 13

Ref country code: CH

Payment date: 20230602

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20230511

Year of fee payment: 13

Ref country code: SE

Payment date: 20230512

Year of fee payment: 13

Ref country code: AT

Payment date: 20230421

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20230519

Year of fee payment: 13